About patients transition pathways, LLC Patient Transition Pathways, LLC is a double mission, first. Both hospitals and patients, as new Medicare new Medicare reform level. As the healthcare industry develops, the patient Pathways Transition Program? performs a positive change by providing a win-win business solution health of the patient health of the patient first. While affect hospitals nationwide to ensure our continuous improvement mentality and future-oriented strategies, Patient Transition Pathways, LLC is redefining patient care a future in the hospital patient care and sustainability go hand – in – hand..
Patient Transition Pathways, LLC today announced the introduction of Patient Transition Pathways Program, developed a business solution, developed by hospitals and home health care implement implement and maintain a sustainable, in-house patient transition program? This comprehensive program provides hospitals with proven approaches to to reduce hospital the the risk of financial penalties for Medicare patients who are within 30 days after discharge from the hospital resumed, as in the Patient Protection and Affordable Care Act of 2010 outlined.The Company has a platform for of gene delivery on advanced on advanced viral systems on by through 80 patent families , which represent one of the broadest patents property on field of. The company also which cooperation with Sigma-Aldrich, and MOLMED Virxsys. Technological licensees include Biogen Idec is, Merck & Co., GlaxoSmithKline and Pfizer.